M Adibzadeh
Overview
Explore the profile of M Adibzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engel A, Adibzadeh M, Pawelec G
Methods Mol Med
. 2012 Feb;
38:97-115.
PMID: 22351268
The need to analyze changes in gene expression patterns occuring in senescent cells has stimulated the search for proper methods to identify the actual differences between young and senescent cells....
2.
Biddison W, Lichtenfels R, Adibzadeh M, Martin R
Curr Protoc Immunol
. 2008 Apr;
Chapter 7:Unit 7.17.
PMID: 18432831
Measurement of in vitro cytotoxic function of human T cells can be accomplished by polyclonal stimulation of T cell effectors using anti-CD3 antibody, which stimulates all cytolytic effector cells, or...
3.
Pawelec G, Adibzadeh M, Rehbein A, Hahnel K, Wagner W, Engel A
Vaccine
. 2000 Feb;
18(16):1666-74.
PMID: 10689146
Immunosenescence is an age-associated dysregulation of immune function which may contribute to the increased susceptibility of the elderly to infectious disease. Although age-associated changes are measurable in the innate immune...
4.
Pawelec G, Wagner W, Adibzadeh M, Engel A
Exp Gerontol
. 1999 Aug;
34(3):419-29.
PMID: 10433396
The term "immunosenescence" refers to an age-associated dysregulation of immune function which contributes to the increased susceptibility of the elderly to infectious disease. Although there are age-associated changes measurable in...
5.
Pawelec G, Engel A, Adibzadeh M
Cancer Immunol Immunother
. 1999 Aug;
48(4):214-7.
PMID: 10431692
Tumours express proteins not commonly found in normal cells, or over-express certain proteins. These may in some cases serve as target antigens for immunological attack. It is therefore essential to...
6.
Li K, Adibzadeh M, Halder T, Kalbacher H, Heinzel S, Muller C, et al.
Cancer Immunol Immunother
. 1998 Oct;
47(1):32-8.
PMID: 9755876
In a search for potentially tumour-specific MHC-class-II-restricted antigens, the immunogenicity of endogenous peptides that had been eluted from HLA-DR molecules of the human melanoma cell line FM3 (HLA-DRB1*02x, DRB1*0401) was...
7.
Pawelec G, Rehbein A, Haehnel K, Merl A, Adibzadeh M
Immunol Rev
. 1998 Feb;
160:31-42.
PMID: 9476663
We have consistently observed that like other normal somatic tissue cells, human T lymphocytes manifest a finite proliferative capacity in culture in vitro. When measured in population doublings (PD), this...
8.
Pawelec G, Adibzadeh M, Solana R, Beckman I
Mech Ageing Dev
. 1997 Feb;
93(1-3):35-45.
PMID: 9089569
Aged persons frequently manifest declining parameters of those immune functions which protect the young against disease. Longitudinal studies are beginning to show that number, type and function of T cells...
9.
Pawelec G, Hambrecht A, Rehbein A, Adibzadeh M
Cytokine
. 1996 Dec;
8(12):877-81.
PMID: 9050744
Interleukin 10 (IL-10) is a pleiotropic T cell-derived cytokine best known for its negative regulatory effects on T cell immunity. It inhibits responses indirectly by downregulating expression of major histocompatibility...
10.
Pawelec G, Adibzadeh M, Bornhak S, Friccius H, Halder T, Kalbacher H, et al.
Immunol Rev
. 1996 Dec;
154:155-73.
PMID: 9034867
No abstract available.